Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Clark

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Drug Safety|December 15, 2010
Clinical implications of pharmacogenetic variation on the effects of statinsSimran D S Maggo, Martin A Kennedy, David W J Clark
European Journal of Clinical Pharmacology|May 21, 2003
Signal that reboxetine use is linked with symptoms of peripheral ischaemia (Raynaud's syndrome)David W J Clark, Ana-Maria Correa-Nunes, I Ralph Edwards
Drug Safety|November 26, 2008
Randomized controlled trials and assessment of drug safetyDavid W J Clark, David M Coulter, Frank M C Besag
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|August 26, 1998
Erythematous, granular, soft tissue lesion of the gingivaW J Clark, V Broumand, J D Ruskin, et al.
Drug Safety|December 14, 2004
Linking pharmacovigilance with pharmacogeneticsDavid W J Clark, Emma Donnelly, David M Coulter, et al.
Headache|September 27, 2003
Activation of pain by sumatriptanDavid M Coulter, J L M Passier, David W J Clark, et al.
British Journal of Clinical Pharmacology|March 18, 2006
QT interval prolongation associated with sibutramine treatmentMira Harrison-Woolrych, David W J Clark, Geraldine R Hill, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1981
Cloning a cDNA for the pro-alpha 2 chain of human type I collagenJ C Myers, M L Chu, S H Faro, et al.
Pharmacoeconomics|August 11, 2006
Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel diseaseVirginia L Priest, Evan J Begg, Sharon J Gardiner, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Drug Safety|December 15, 2010
Clinical implications of pharmacogenetic variation on the effects of statinsSimran D S Maggo, Martin A Kennedy, David W J Clark
European Journal of Clinical Pharmacology|May 21, 2003
Signal that reboxetine use is linked with symptoms of peripheral ischaemia (Raynaud's syndrome)David W J Clark, Ana-Maria Correa-Nunes, I Ralph Edwards
Drug Safety|November 26, 2008
Randomized controlled trials and assessment of drug safetyDavid W J Clark, David M Coulter, Frank M C Besag
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|August 26, 1998
Erythematous, granular, soft tissue lesion of the gingivaW J Clark, V Broumand, J D Ruskin, et al.
Drug Safety|December 14, 2004
Linking pharmacovigilance with pharmacogeneticsDavid W J Clark, Emma Donnelly, David M Coulter, et al.
Headache|September 27, 2003
Activation of pain by sumatriptanDavid M Coulter, J L M Passier, David W J Clark, et al.
British Journal of Clinical Pharmacology|March 18, 2006
QT interval prolongation associated with sibutramine treatmentMira Harrison-Woolrych, David W J Clark, Geraldine R Hill, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1981
Cloning a cDNA for the pro-alpha 2 chain of human type I collagenJ C Myers, M L Chu, S H Faro, et al.
Pharmacoeconomics|August 11, 2006
Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel diseaseVirginia L Priest, Evan J Begg, Sharon J Gardiner, et al.
Pageof 3